Stock GPCR STRUCTURE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Real-time Estimate Cboe BZX
Other stock markets
 01:38:32 2024-05-14 pm EDT 		5-day change 1st Jan Change
36.07 USD +0.22% Intraday chart for Structure Therapeutics Inc. -8.62% -11.83%
May. 09 Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ADRs Edge Higher; Lufax Climbs Almost 46%
DJ
Structure Therapeutics Q4 Loss Widens
MT
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Structure's diabetes pill misses weight-loss expectations in mid-stage trial
RE
Structure Therapeutics Inc. Provides Comprehensive GSBR-1290 Program Update
CI
Structure Therapeutics Q3 Loss Narrows
MT
Structure Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Structure Therapeutics Announces Positive Results From Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
CI
Structure Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
GL
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
GL
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data
RE
Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
GL
Structure Therapeutics Inc. has completed an IPO in the amount of $161.1 million.
CI
Structure Therapeutics Inc. has filed an IPO in the amount of $100 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GPCR Stock
  4. News Structure Therapeutics Inc.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW